Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC

BSE2810.90-9.95 (-0.35 %)

PREV CLOSE ( ) 2820.85

OPEN PRICE ( ) 2810.25

BID PRICE (QTY) 2810.55 (2)

OFFER PRICE (QTY) 2814.95 (10)

VOLUME 1290

TODAY'S LOW / HIGH ( )2780.50 2818.45

52 WK LOW / HIGH ( )1924.3 3515.95

NSE2812.00-7.1 (-0.25 %)

PREV CLOSE( ) 2819.10

OPEN PRICE ( ) 2819.00

BID PRICE (QTY) 2812.00 (1890)

OFFER PRICE (QTY) 2813.80 (7)

VOLUME 43590

TODAY'S LOW / HIGH( ) 2780.00 2819.00

52 WK LOW / HIGH ( )1921 3515.7

Quarters

Select year

( in Million)

Particulars

Jun 2025

Mar 2025

Dec 2024

Sep 2024

Audited / UnAudited

UnAudited

Net Sales

8051.7

9743.7

9494.2

10107.7

Total Expenditure

5539.7

6411.8

6575

6890.6

PBIDT (Excl OI)

2512

3331.9

2919.2

3217.1

Other Income

437.2

406.8

350.7

345.4

Operating Profit

2949.2

3738.7

3269.9

3562.5

Interest

4.2

5.8

0.9

2.7

Exceptional Items

46.9

PBDT

2945

3732.9

3269

3606.7

Depreciation

155.2

147.2

188

168.6

Profit Before Tax

2789.8

3585.7

3081

3438.1

Tax

739.7

957

782.2

913.1

Provisions and contingencies

Profit After Tax

2050.1

2628.7

2298.8

2525

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

2050.1

2628.7

2298.8

2525

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

2050.1

2628.7

2298.8

2525

Equity Capital

1694.1

Face Value (IN RS)

Reserves

Calculated EPS

12.10

15.51

13.56

14.90

Calculated EPS (Annualised)

48.40

62.06

54.27

59.61

No of Public Share Holdings

42351510

% of Public Share Holdings

PBIDTM% (Excl OI)

31.19

34.19

30.74

31.82

PBIDTM%

36.62

38.37

34.44

35.24

PBDTM%

36.57

38.31

34.43

35.68

PBTM%

34.64

36.80

32.45

34.01

PATM%

25.46

26.97

24.21

24.98

Notes

Risk Disclosures on Derivatives

Quarterly Results

GLAXOSMITHKLINE PHARMACEUTICALS LTD.